Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

New theories in interstitial cystitis

Abstract

Interstitial cystitis (IC) is a chronic symptom-complex characterized by pathological sensation of the bladder (i.e. bladder pain in addition to augmented sensory signals such as urinary frequency and urgency) without evidence of bacterial cystitis or other identifiable lower urinary tract disease. Patients with IC typically describe feeling the urge to void frequently, as well as pain in the bladder and/or urethra. The painful sensation may be described as burning, pressure, sharp, or aching, and is often difficult for the patient to localize precisely. Multiple theories as to the cause of IC have been proposed with varying degrees of evidence. The current body of literature supports the idea that IC is associated with an intrinsic pathology of the bladder urothelial cells. The identification and complete characterization of antiproliferative factor (APF), which is uniquely expressed by urothelial cells in bladders affected by IC, are major advances in the understanding of IC. Additionally, urothelial cells have been likened to neurons because of their ability to express neuronal receptors and release neurotransmitters. The purinergic pathway has been shown to be upregulated in urothelial cells in bladders affected by IC. These new findings should help to direct the development of newer clinical treatments for IC. A complete understanding of IC will only be possible with parallel advances in both basic and clinical sciences.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Ratner V (2001) Interstitial cystitis: a chronic inflammatory bladder condition. World J Urol 19: 157–159

    Article  CAS  Google Scholar 

  2. Gillenwater JY and Wein AJ (1988) Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28–29, 1987. J Urol 140: 203–206

    Google Scholar 

  3. Keay SK et al. (2001) Sensitivity and specificity of antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor as urine markers for interstitial cystitis. Urology 57(6 Suppl 1): 9–14

    Article  CAS  Google Scholar 

  4. Erickson DR et al. (2002) A comparison of multiple urine markers for interstitial cystitis. J Urol 167: 2461–2469

    Article  CAS  Google Scholar 

  5. Keay S et al. (2003) Current and future directions in diagnostic markers in interstitial cystitis. Int J Urol 10 (Suppl): S27–S30

    Article  Google Scholar 

  6. Erickson DR et al. (2004) Do the NIDDK cystoscopic criteria associate with other clinical and objective features of interstitial cystitis? J Urol, in press

  7. Waxman JA et al. (1998) Cystoscopic findings consistent with interstitial cystitis in normal women undergoing tubal ligation. J Urol 160:1663–1667

    Article  CAS  Google Scholar 

  8. Keay S and Warren JW (1998) A hypothesis for the etiology of interstitial cystitis based upon inhibition of bladder epithelial repair. Med Hypotheses 51: 79–83

    Article  CAS  Google Scholar 

  9. Nigro DA et al. (1997) Associations among cystoscopic and urodynamic findings for women enrolled in the Interstitial Cystitis Data Base (ICDB) Study. Urology 49(5A Suppl): 86–92

    Article  CAS  Google Scholar 

  10. Kusek JW and Nyberg LM (2001) The epidemiology of interstitial cystitis: Is it time to expand our definition? Urology 57 (Suppl 6A): 95–99

    Article  CAS  Google Scholar 

  11. Abrams P et al. (2002) The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21: 167–178

    Article  Google Scholar 

  12. Luzzi G and O'Leary M (1999) Chronic pelvic pain syndrome. Is common and poorly understood – a fresh approach is needed. Br Med J 318: 1227–1228

    Article  CAS  Google Scholar 

  13. Parsons CL and Albo M (2002) Intravesical potassium sensitivity in patients with prostatitis. J Urol 168: 1054–1057

    Article  Google Scholar 

  14. Dimitrakov JD (2001) A case of familial clustering of interstitial cystitis and chronic pelvic pain syndrome. Urology 58: 281

    Article  CAS  Google Scholar 

  15. Keay S et al. (2004) Antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor in men with interstitial cystitis versus chronic pelvic pain syndrome. Urology 63: 22–26

    Article  Google Scholar 

  16. Yilmaz U et al. (2004) Intravesical potassium chloride sensitivity test in men with chronic pelvic pain syndrome. J Urol 172: 548–550

    Article  CAS  Google Scholar 

  17. Oravisto KJ et al. (1970) Interstitial cystitis: clinical and immunological findings. Scand J Urol Nephrol 4: 37–42

    Article  CAS  Google Scholar 

  18. Skoluda D et al. (1974) Kritische bemerkungen zur immunopathogenese der interstitiellen cystitis. Urologe 13: 15–23

    CAS  PubMed  Google Scholar 

  19. Ruggieri MR et al. (1994) Current findings and future research avenues in the study of interstitial cystitis. Urol Clin North Am 21: 163–176

    CAS  PubMed  Google Scholar 

  20. Keay S et al. (2000) Bladder epithelial cells from interstitial cystitis patients produce an inhibitor of HB-EGF production. J Urol 64: 2112–2118

    Article  Google Scholar 

  21. Parsons CL et al. (1998) The role of urinary potassium in the pathogenesis and diagnosis of interstitial cystitis. J Urol 159: 1862–1866

    Article  CAS  Google Scholar 

  22. Buffington CA and Woodworth BE (1997) Excretion of fluorescein in the urine of women with interstitial cystitis. J Urol 158: 786–789

    Article  CAS  Google Scholar 

  23. Keay S et al. (2003) Changes in human bladder cell gene expression associated with interstitial cystitis or antiproliferative factor treatment. Physiol Genomics 14: 107–115

    Article  CAS  Google Scholar 

  24. Keay S et al. (2003) Decreased in vitro proliferation of bladder epithelial cells from patients with interstitial cystitis. Urology 61: 1278–1284

    Article  Google Scholar 

  25. Sun Y et al. (2001) Augmented stretch activated adenosine triphosphate release from bladder uroepithelial cells in patients with interstitial cystitis. J Urol 166: 1951–1956

    Article  CAS  Google Scholar 

  26. Tempest HV et al. (2004) P2X2 and P2X3 receptor expression in human bladder urothelium and changes in interstitial cystitis. BJU Int 93: 1344–1348

    Article  CAS  Google Scholar 

  27. Sun Y and Chai TC (2004) Up-regulation of P2X3 receptor during stretch of bladder urothelial cells from patients with interstitial cystitis. J Urol 171: 448–452

    Article  Google Scholar 

  28. Keay SK et al. (2004) An antiproliferative factor from interstitial cystitis patients is a frizzled 8 protein-related sialoglycopeptide. Proc Natl Acad Sci USA 101: 11803–11808

    Article  CAS  Google Scholar 

  29. Seguchi T et al. (1992) Interleukin-6 activity in urine and serum in patients with bladder carcinoma. J Urol 148: 791–794

    Article  CAS  Google Scholar 

  30. Rhee E et al. (1998) Urinary IL-6 is elevated in patients with urolithiasis. J Urol 160: 2284–2288

    Article  CAS  Google Scholar 

  31. Davidoff R et al. (1997) Multiple urinary cytokine levels of bacterial cystitis. J Urol 157: 1980–1985

    Article  CAS  Google Scholar 

  32. Chai TC et al. (2000) Bladder stretch alters urinary levels of HB-EGF and antiproliferative factor in interstitial cystitis patients. J Urol 163: 1440–1444

    Article  CAS  Google Scholar 

  33. Chai TC et al. (2000) Percutaneous sacral 3rd nerve root (S3) neurostimulation improves symptoms and normalizes urinary HB-EGF levels and antiproliferative activity in interstitial cystitis patients. Urology 55: 643–646

    Article  CAS  Google Scholar 

  34. Birder LA et al. (2002) Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1. Nat Neurosci 5: 856–860

    Article  CAS  Google Scholar 

  35. Chess-Williams R (2002) Muscarinic receptors of the urinary bladder: detrusor, urothelial and prejunctional. Auton Autacoid Pharmacol 22: 133–145

    Article  CAS  Google Scholar 

  36. Stein RJ et al. (2004) Cool (TRPM8) and hot (TRPV1) receptors in the bladder and male genital tract. J Urol 172: 1175–1178

    Article  CAS  Google Scholar 

  37. Kumar V et al. (2004) Characteristics of adenosine triphosphatase release from porcine and human normal bladder. J Urol 172: 744–747

    Article  CAS  Google Scholar 

  38. Birder LA et al. (1998) Adrenergic- and capsaicin-evoked nitric oxide release from urothelium and afferent nerves in urinary bladder. Am J Physiol 275: F226–F229

    CAS  PubMed  Google Scholar 

  39. Birder LA et al. (2002) Beta-adrenoceptor agonists stimulate endothelial nitric oxide synthase in rat urinary bladder urothelial cells. J Neurosci 22: 8063–8070

    Article  CAS  Google Scholar 

  40. Logadottir YR et al. (2004) Intravesical nitric oxide production discriminates between classic and nonulcer interstitial cystitis. J Urol 171: 1148–1150

    Article  CAS  Google Scholar 

  41. Burnstock G (1999) Release of vasoactive substances from endothelial cells by shear stress and purinergic mechanosensory transduction. J Anat 194: 335–342

    Article  CAS  Google Scholar 

  42. Ferguson DR et al. (1997) ATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes–a possible sensory mechanism? J Physiol 505: 503–511

    Article  CAS  Google Scholar 

  43. Palea S et al. (1993) Evidence for purinergic neurotransmission in human urinary bladder affected by interstitial cystitis. J Urol 150: 2007–2012

    Article  CAS  Google Scholar 

  44. Freeman MR et al. (1997) Heparin-binding EGF-like growth factor is an autocrine growth factor for human urothelial cells and is synthesized by epithelial and smooth muscle cells in the human bladder. J Clin Invest 99: 1028–1036

    Article  CAS  Google Scholar 

  45. Propert KJ et al. (2002) Pitfalls in the design of clinical trials for interstitial cystitis. Urology 60: 742–748

    Article  Google Scholar 

  46. Sant GR et al. (2003) A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis. J Urol 170: 810–815

    Article  CAS  Google Scholar 

  47. Alexander RB et al. (2004) A randomized trial of ciprofloxacin and tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Int Med 141: 581–589.

    Article  CAS  Google Scholar 

  48. Payne C et al. (2004) Phase II safety and efficacy study of single dose of intravesical resiniferatoxin (RTX) in patients with interstitial cystitis [abstract]. Neurourol Urodyn 23: 606

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Toby C Chai.

Ethics declarations

Competing interests

Susan Keay is one of the inventors on the patents for antiproliferative factor, the use of HB-EGF/EGF for diagnosis of IC, and the use of HB-EGF for treatment of IC.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chai, T., Keay, S. New theories in interstitial cystitis. Nat Rev Urol 1, 85–89 (2004). https://doi.org/10.1038/ncpuro0057

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro0057

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing